v3.26.1
Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balances at Dec. 31, 2023 $ 149,649 $ 6 $ 709,030 $ 21 $ (559,408)
Common Stock Balance, Shares at Dec. 31, 2023   6,154,890      
Exercise of common stock options 271   271    
Exercise of common stock options, Shares   6,373      
Issuance of common stock under Employee Stock Purchase Plan 1,848   1,848    
Issuance of common stock under Employee Stock Purchase Plan, Shares   56,517      
Vesting of restricted stock units (0)        
Vesting of restricted stock units, Shares   169,453      
Stock transaction associated with taxes withheld on restricted stock units (509)   (509)    
Stock transaction associated with taxes withheld on restricted stock units,Shares   (11,449)      
Stock-based compensation expense 24,687   24,687    
Issuance of common stock in connection with the underwritten offering, net of issuance costs , Shares   1,447,876      
Issuance of common stock in connection with the underwritten offering, net of issuance costs 71,527 $ 1 71,526    
Issuance of common stock to Ipsen Biopharmaceuticals, Inc. (USA) under the Ipsen Investment Agreement, Shares   482,738      
Issuance of common stock to Ipsen Biopharmaceuticals, Inc. (USA) under the Ipsen Investment Agreement 24,571 $ 1 24,570    
Net unrealized income (loss) on available-for-sale securities 18     18  
Net Income (Loss) (227,461)       (227,461)
Balances at Dec. 31, 2024 44,601 $ 8 831,423 39 (786,869)
Common Stock Balance, Shares at Dec. 31, 2024   8,306,398      
Exercise of common stock options 4   4    
Exercise of common stock options, Shares   826      
Issuance of common stock under Employee Stock Purchase Plan 372   372    
Issuance of common stock under Employee Stock Purchase Plan, Shares   52,277      
Vesting of restricted stock units 1 $ 1      
Vesting of restricted stock units, Shares   252,107      
Stock transaction associated with taxes withheld on restricted stock units (332)   (332)    
Stock transaction associated with taxes withheld on restricted stock units,Shares   (27,299)      
Stock-based compensation expense 14,008   14,008    
Net unrealized income (loss) on available-for-sale securities (20)     (20)  
Net Income (Loss) (191,086)       (191,086)
Balances at Dec. 31, 2025 $ (132,452) $ 9 $ 845,475 $ 19 $ (977,955)
Common Stock Balance, Shares at Dec. 31, 2025   8,584,309